<DOC>
	<DOCNO>NCT01004211</DOCNO>
	<brief_summary>To date , fluorescence narrow band image cystoscopy test many prospective within patient trial `` add '' procedure . This result bias allow determine real impact innovative technology bladder cancer management . Hereby propose first prospective randomize trial compare narrow band image trans urethral resection stand alone procedure versus white light transurethral resection . The primary end point assess recurrence rate bladder cancer lesion treatment modality . The study design disclose inferior recurrence rate ( estimate 10 % ) group treat narrow band image transurethral resection respect control group , treat standard transurethral resection .</brief_summary>
	<brief_title>Prospective Randomized Comparison Transurethral Resection Mean White Light Narrow Band Imaging</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>All patient must older 18 year age female patient pregnant , breast feeding adequate contraceptive measure exclude . All patient provide write informed consent prior study . Consecutive patient 2 center Liguria ( National Institute Cancer Research Genova Centro Urologico di Eccellenza ASL 1 Imperia ) overt suspect non muscle invasive bladder cancer , include Cis detect mean random biopsy positive urinary cytology , include study randomize 2 treatment A , B arm . Patients muscle invasive bladder cancer exclude . Patients submit immediate radical cystectomy transurethral resection , irrespective clinical stage , exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>bladder cancer</keyword>
	<keyword>recurrence</keyword>
</DOC>